260 related articles for article (PubMed ID: 29555685)
1. p62/sequestosome 1 deficiency accelerates osteoclastogenesis
Zach F; Polzer F; Mueller A; Gessner A
J Biol Chem; 2018 Jun; 293(24):9530-9541. PubMed ID: 29555685
[TBL] [Abstract][Full Text] [Related]
2. A novel mutation (K378X) in the sequestosome 1 gene associated with increased NF-kappaB signaling and Paget's disease of bone with a severe phenotype.
Rea SL; Walsh JP; Ward L; Yip K; Ward BK; Kent GN; Steer JH; Xu J; Ratajczak T
J Bone Miner Res; 2006 Jul; 21(7):1136-45. PubMed ID: 16813535
[TBL] [Abstract][Full Text] [Related]
3. Zoledronic acid prevents pagetic-like lesions and accelerated bone loss in the p62
Daroszewska A; Rose L; Sarsam N; Charlesworth G; Prior A; Rose K; Ralston SH; van 't Hof RJ
Dis Model Mech; 2018 Aug; 11(9):. PubMed ID: 30154079
[TBL] [Abstract][Full Text] [Related]
4. A quest for clarity in bone erosion: The role of sequestosome 1 in Paget's disease of bone.
Michalski MN; Williams BO
J Biol Chem; 2018 Jun; 293(24):9542-9543. PubMed ID: 29907733
[TBL] [Abstract][Full Text] [Related]
5. A SQSTM1/p62 mutation linked to Paget's disease increases the osteoclastogenic potential of the bone microenvironment.
Hiruma Y; Kurihara N; Subler MA; Zhou H; Boykin CS; Zhang H; Ishizuka S; Dempster DW; Roodman GD; Windle JJ
Hum Mol Genet; 2008 Dec; 17(23):3708-19. PubMed ID: 18765443
[TBL] [Abstract][Full Text] [Related]
6. p62 ubiquitin binding-associated domain mediated the receptor activator of nuclear factor-kappaB ligand-induced osteoclast formation: a new insight into the pathogenesis of Paget's disease of bone.
Yip KH; Feng H; Pavlos NJ; Zheng MH; Xu J
Am J Pathol; 2006 Aug; 169(2):503-14. PubMed ID: 16877352
[TBL] [Abstract][Full Text] [Related]
7. A FKBP5 mutation is associated with Paget's disease of bone and enhances osteoclastogenesis.
Lu B; Jiao Y; Wang Y; Dong J; Wei M; Cui B; Sun Y; Wang L; Zhang B; Chen Z; Zhao Y
Exp Mol Med; 2017 May; 49(5):e336. PubMed ID: 28524179
[TBL] [Abstract][Full Text] [Related]
8. Canine distemper virus induces human osteoclastogenesis through NF-kappaB and sequestosome 1/P62 activation.
Selby PL; Davies M; Mee AP
J Bone Miner Res; 2006 Nov; 21(11):1750-6. PubMed ID: 17002577
[TBL] [Abstract][Full Text] [Related]
9. Osteoclast differentiation from circulating mononuclear precursors in Paget's disease is hypersensitive to 1,25-dihydroxyvitamin D(3) and RANKL.
Neale SD; Smith R; Wass JA; Athanasou NA
Bone; 2000 Sep; 27(3):409-16. PubMed ID: 10962353
[TBL] [Abstract][Full Text] [Related]
10. The p62 P392L mutation linked to Paget's disease induces activation of human osteoclasts.
Chamoux E; Couture J; Bisson M; Morissette J; Brown JP; Roux S
Mol Endocrinol; 2009 Oct; 23(10):1668-80. PubMed ID: 19589897
[TBL] [Abstract][Full Text] [Related]
11. Etiology of Paget's disease and osteoclast abnormalities.
Reddy SV
J Cell Biochem; 2004 Nov; 93(4):688-96. PubMed ID: 15389972
[TBL] [Abstract][Full Text] [Related]
12. Mutant p62P392L stimulation of osteoclast differentiation in Paget's disease of bone.
Sundaram K; Shanmugarajan S; Rao DS; Reddy SV
Endocrinology; 2011 Nov; 152(11):4180-9. PubMed ID: 21878516
[TBL] [Abstract][Full Text] [Related]
13. Etiologic factors in Paget's disease of bone.
Reddy SV
Cell Mol Life Sci; 2006 Feb; 63(4):391-8. PubMed ID: 16429324
[TBL] [Abstract][Full Text] [Related]
14. A point mutation in the ubiquitin-associated domain of SQSMT1 is sufficient to cause a Paget's disease-like disorder in mice.
Daroszewska A; van 't Hof RJ; Rojas JA; Layfield R; Landao-Basonga E; Rose L; Rose K; Ralston SH
Hum Mol Genet; 2011 Jul; 20(14):2734-44. PubMed ID: 21515589
[TBL] [Abstract][Full Text] [Related]
15. Effect of a rare genetic variant of TM7SF4 gene on osteoclasts of patients with Paget's disease of bone.
Laurier E; Amiable N; Gagnon E; Brown JP; Michou L
BMC Med Genet; 2017 Nov; 18(1):133. PubMed ID: 29145829
[TBL] [Abstract][Full Text] [Related]
16. Increased IL-6 expression in osteoclasts is necessary but not sufficient for the development of Paget's disease of bone.
Teramachi J; Zhou H; Subler MA; Kitagawa Y; Galson DL; Dempster DW; Windle JJ; Kurihara N; Roodman GD
J Bone Miner Res; 2014 Jun; 29(6):1456-65. PubMed ID: 24339057
[TBL] [Abstract][Full Text] [Related]
17. New insights into the role of sequestosome 1/p62 mutant proteins in the pathogenesis of Paget's disease of bone.
Rea SL; Walsh JP; Layfield R; Ratajczak T; Xu J
Endocr Rev; 2013 Aug; 34(4):501-24. PubMed ID: 23612225
[TBL] [Abstract][Full Text] [Related]
18. Aged G Protein-Coupled Receptor Kinase 3 (Grk3)-Deficient Mice Exhibit Enhanced Osteoclastogenesis and Develop Bone Lesions Analogous to Human Paget's Disease of Bone.
Rabjohns EM; Rampersad RR; Ghosh A; Hurst K; Eudy AM; Brozowski JM; Lee HH; Ren Y; Mirando A; Gladman J; Bowser JL; Berg K; Wani S; Ralston SH; Hilton MJ; Tarrant TK
Cells; 2023 Mar; 12(7):. PubMed ID: 37048054
[TBL] [Abstract][Full Text] [Related]
19. Bioactive iron oxide nanoparticles suppress osteoclastogenesis and ovariectomy-induced bone loss through regulating the TRAF6-p62-CYLD signaling complex.
Liu L; Jin R; Duan J; Yang L; Cai Z; Zhu W; Nie Y; He J; Xia C; Gong Q; Song B; Anderson JM; Ai H
Acta Biomater; 2020 Feb; 103():281-292. PubMed ID: 31866569
[TBL] [Abstract][Full Text] [Related]
20. Contributions of the measles virus nucleocapsid gene and the SQSTM1/p62(P392L) mutation to Paget's disease.
Kurihara N; Hiruma Y; Yamana K; Michou L; Rousseau C; Morissette J; Galson DL; Teramachi J; Zhou H; Dempster DW; Windle JJ; Brown JP; Roodman GD
Cell Metab; 2011 Jan; 13(1):23-34. PubMed ID: 21195346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]